Price
1,401
-1.22%52W Range
Market Cap
₹1,13,170.07 Cr
Traded: ₹1,339.49 Cr (1.18%) 0.0x
Free Float: ₹18,401.45 Cr (7.28% of FF traded)
Volume · 60D trend
95.41 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Held by ETFs
66 ETFs hold cipla · sorted by weight
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +7.0% | +8.0% | +7.0% | -- | +2.0% | Decelerating |
| Profit | +12.0% | +11.0% | +13.0% | -- | -21.0% | Stable |
| Return | +10.0% | +8.0% | +12.0% | -13.0% | -- | Stable |
| ROE | +13.0% | +15.0% | +15.0% | -- | -- | Stable |
Quarterly Results
Mar 2026
13 MayDec 2025
23 JanSep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Shareholding Pattern
LAX.SH
Exchange Filings
50Please find attached the Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2026.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Please find enclosed Newspaper advertisement titled "Notice of 90th AGM to be held through Video Conferencing, Record Date and Final Dividend
We are enclosing hereby a copy of transcript of the Company''s Q4 FY26 earnings conference call dated 13th May, 2026
Please find attached newspaper advertisement
In compliance with the provisions of regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
Outcome of board meeting on 13 May 2026
Record date for the purpose of payment of final dividend for FY 2025-26
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Grant of stock options and employee stock appreciation rights (ESARs)
Appointment of Cost Auditor
Press release for Q4 and FY 2025-26
Appointment of Mr Sushrut Kulkarni as Senior Management Personnel of the Company w.e.f 18 May 2026
Investor Presentation for Q4 and FY 2025-26
Declaration of final dividend of INR 13 per equity share for FY ended March 31, 2026
Please find enclosed the result dated May 13, 2026
Newspaper publication under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Please find enclosed intimation
USFDA inspection at Company''s manufacturing facility in Goa, India
Newspaper publication regarding Second 100-days Campaign -''Saksham Niveshak''
We are enclosing herewith earnings call intimation scheduled to be held on 13th May 2026
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve 1. the Standalone and Consolidated Audited ....
Resignation of Mr Umang Vohra as Director of the Company w.e.f. 1st April, 2026
Categorisation of Mr Saurabh Gambhir and Mr Satyavan Manikani as Senior Management Personnel of the Company w.e.f. 1st April, 2026
Please find attached newspaper publication regarding opening of special window of lodgement of transfer and dematerialisation of physical shares.
Mr Pradeep Bhadauria, Global Chief Scientific Officer has resigned to pursue interests outside Cipla and his last working day will be 31st March, 2026.
Result of the Postal Ballot along with Scrutinizer''s Report
Please find attached intimation regarding appointment of Vice Chairman and tenure completion of ID
Investment in Cipla (EU) Limited, wholly owned subsidiary of the Company
Scheme of Amalgamation between Inzpera Healthsciences Limited, wholly owned subsidiary of the Company (''Transferor Company'') with the Company (''Transferee Company'')
In compliance with the provision of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operation and Administrative Committee ....
Please find enclosed intimation.
please find enclosed intimation.
Please find enclosed Intimation
Please find attached disclosure on ESG Rating.
Newspaper advertisement for Notice of Postal Ballot and e-voting information
Postal Ballot Notice dated 23rd January, 2026
Please find enclosed intimation
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 of schedule of Analyst / Institutional Investor Meeting
Please find enclosed intimation.
Disclosure under Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Appointment of Global Chief People Office and Senior Management Personnel
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative ....
We are enclosing hereby a copy of the transcript of the Company''s Q3 FY26 earning conference call dated 23rd January, 2026.
Please find attached newspaper advertisement
Please find attached financial results for quarter and nine months ended 31st December 2025
Annual Reports
15Credit Ratings
6Concalls
64Jan 2026
31 Jan 2026Nov 2025
30 Nov 2025Jul 2025
31 Jul 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Jan 2025
31 Jan 2025Nov 2024
30 Nov 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Jan 2024
31 Jan 2024Oct 2023
31 Oct 2023Aug 2023
31 Aug 2023Jul 2023
31 Jul 2023Jul 2023
31 Jul 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jul 2022
31 Jul 2022May 2022
31 May 2022Jan 2022
31 Jan 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021May 2021
31 May 2021May 2021
31 May 2021Feb 2021
28 Feb 2021Feb 2021
28 Feb 2021Jan 2021
31 Jan 2021Nov 2020
30 Nov 2020Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Aug 2020
31 Aug 2020May 2020
31 May 2020May 2020
31 May 2020Feb 2020
29 Feb 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Nov 2019
30 Nov 2019Aug 2019
31 Aug 2019Aug 2019
31 Aug 2019Jun 2019
30 Jun 2019May 2019
31 May 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Nov 2018
30 Nov 2018Aug 2018
31 Aug 2018May 2018
31 May 2018Feb 2018
28 Feb 2018Feb 2018
28 Feb 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017May 2017
31 May 2017May 2017
31 May 2017Feb 2017
28 Feb 2017Nov 2016
30 Nov 2016Aug 2016
31 Aug 2016May 2016
31 May 2016Nov 2015
30 Nov 2015Aug 2015
31 Aug 2015Detailed Financials
Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,541 | 7,074 | 7,589 | 6,957 | 6,730 | 7,073 | 7,051 | 6,694 | 6,163 | 6,604 | 6,678 | 6,329 | 5,739 | 5,810 |
| Expenses | 5,586 | 5,819 | 5,695 | 5,179 | 5,192 | 5,084 | 5,165 | 4,978 | 4,847 | 4,856 | 4,944 | 4,835 | 4,566 | 4,403 |
| Operating Profit | 955 | 1,255 | 1,895 | 1,778 | 1,538 | 1,989 | 1,886 | 1,716 | 1,316 | 1,748 | 1,734 | 1,494 | 1,174 | 1,408 |
| OPM % | 15.0% | 18.0% | 25.0% | 26.0% | 23.0% | 28.0% | 27.0% | 26.0% | 21.0% | 26.0% | 26.0% | 24.0% | 20.0% | 24.0% |
| Other Income | 148 | -70 | 269 | 259 | 289 | 222 | 191 | 160 | 249 | -10 | 176 | 136 | -48 | 114 |
| Interest | 13 | 14 | 13 | 14 | 14 | 15 | 15 | 18 | 18 | 30 | 26 | 16 | 34 | 32 |
| Depreciation | 383 | 278 | 297 | 253 | 309 | 280 | 272 | 247 | 288 | 233 | 290 | 239 | 346 | 272 |
| Profit Before Tax | 707 | 893 | 1,854 | 1,770 | 1,504 | 1,916 | 1,789 | 1,611 | 1,259 | 1,474 | 1,594 | 1,375 | 745 | 1,218 |
| Tax % | 22.0% | 24.0% | 27.0% | 27.0% | 19.0% | 17.0% | 27.0% | 27.0% | 26.0% | 28.0% | 28.0% | 28.0% | 30.0% | 34.0% |
| Net Profit | 543 | 674 | 1,353 | 1,292 | 1,214 | 1,575 | 1,305 | 1,175 | 932 | 1,068 | 1,155 | 998 | 522 | 808 |
| Exceptional Items | 0 | -276 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -195 | 0 | 0 | -182 | 0 |
| EPS (Rs) | 6.9 | 8.4 | 16.7 | 16.1 | 15.1 | 19.4 | 16.1 | 14.6 | 11.6 | 13.1 | 14.0 | 12.3 | 6.5 | 9.9 |
| Sales Growth (YoY) | -2.8% | 0.0% | 7.6% | 3.9% | 9.2% | 7.1% | 5.6% | 5.8% | 7.4% | 13.7% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -7.5% | -6.8% | 9.1% | 3.4% | -4.8% | 0.3% | 5.3% | 8.6% | -6.7% | -1.1% | 5.5% | 10.3% | -1.2% | -- |
| OP Growth (YoY) | -37.9% | -36.9% | 0.5% | 3.6% | 16.9% | 13.8% | 8.8% | 14.9% | 12.1% | 24.1% | -- | -- | -- | -- |
| OP Growth (QoQ) | -23.9% | -33.8% | 6.6% | 15.6% | -22.7% | 5.5% | 9.9% | 30.4% | -24.7% | 0.8% | 16.1% | 27.3% | -16.6% | -- |
| Profit Growth (YoY) | -55.0% | -44.0% | 4.0% | 10.0% | 30.0% | 31.0% | 15.0% | 18.0% | 49.0% | 49.0% | 43.0% | 45.0% | 62.0% | 10.0% |
| EPS Growth (YoY) | -54.6% | -57.0% | 3.7% | 10.2% | 30.1% | 48.7% | 15.1% | 18.3% | 78.7% | 31.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -17.9% | -50.0% | 4.2% | 6.2% | -22.2% | 20.6% | 10.6% | 25.4% | -11.1% | -6.6% | 13.6% | 89.4% | -34.4% | -- |
| OP Margin | 14.6% | 17.7% | 25.0% | 25.6% | 22.9% | 28.1% | 26.8% | 25.6% | 21.4% | 26.5% | 26.0% | 23.6% | 20.5% | 24.2% |
| Net Margin | 8.3% | 9.5% | 17.8% | 18.6% | 18.0% | 22.3% | 18.5% | 17.6% | 15.1% | 16.2% | 17.3% | 15.8% | 9.1% | 13.9% |
| Material Cost % | 34.4% | 37.2% | 32.9% | 31.2% | 32.5% | 32.0% | 32.4% | 32.8% | 33.3% | 33.6% | 34.6% | 35.3% | 36.0% | 34.5% |
| Employee Cost % | 21.6% | 18.7% | 17.3% | 18.9% | 18.3% | 16.9% | 17.1% | 17.8% | 17.6% | 16.2% | 16.3% | 16.9% | 16.8% | 16.3% |
| P/S | 4.02 | 3.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 29.17 | 22.96 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.29 | 3.17 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |